35246016|t|Overexpression of microRNA-381-3p ameliorates hypoxia/ischemia-induced neuronal damage and microglial inflammation via regulating the C-C chemokine receptor type 2 /nuclear transcription factor-kappa B axis.
35246016|a|microRNAs, as small endogenous RNAs, influence umpteen sophisticated cellular biological functions regarding neurodegenerative and cerebrovascular diseases. Here, we interrogated miR-381-3p's influence on BV2 activation and neurotoxicity in ischemic and hypoxic environment. Oxygen-glucose deprivation (OGD) was adopted to induce microglial activation and HT-22 neuron damage. Quantitative polymerase chain reaction (qRT-PCR) was taken to check miR-381-3p expression in OGD-elicited BV2 cells and HT-22 neurons. It transpired that miR-381-3p expression was lowered in BV2 cells and HT-22 cells elicited by OGD. miR-381-3p up-regulation remarkably hampered inflammatory mediator expression in BV2 cells induced by OGD and weakened HT22 neuron apoptosis. In vivo, miR-381-3p expression was abated in HI rats' ischemic lesions, and miR-381-3p up-regulation could ameliorate inflammation and neuron apoptosis in their brain. C-C chemokine receptor type 2 (CCR2) was identified as the downstream target of miR-381-3p, and miR-381-3p suppressed the CCR2/NF-kappaB pathway to mitigate microglial activation and neurotoxicity. Therefore, we believed that miR-381-3p overexpression exerts anti-inflammation and anti-apoptosis in ischemic brain injury by targeting CCR2.
35246016	46	53	hypoxia	Disease	MESH:D000860
35246016	54	62	ischemia	Disease	MESH:D007511
35246016	71	86	neuronal damage	Disease	MESH:D009410
35246016	102	114	inflammation	Disease	MESH:D007249
35246016	134	163	C-C chemokine receptor type 2	Gene	60463
35246016	317	363	neurodegenerative and cerebrovascular diseases	Disease	MESH:D019636
35246016	432	445	neurotoxicity	Disease	MESH:D020258
35246016	462	469	hypoxic	Disease	MESH:D002534
35246016	483	489	Oxygen	Chemical	MESH:D010100
35246016	490	497	glucose	Chemical	MESH:D005947
35246016	564	569	HT-22	CellLine	CVCL:0321
35246016	570	583	neuron damage	Disease	MESH:D009410
35246016	691	694	BV2	CellLine	CVCL:0182
35246016	705	710	HT-22	CellLine	CVCL:0321
35246016	776	779	BV2	CellLine	CVCL:0182
35246016	790	795	HT-22	CellLine	CVCL:0321
35246016	864	885	inflammatory mediator	Disease	MESH:C567355
35246016	900	903	BV2	CellLine	CVCL:0182
35246016	938	942	HT22	CellLine	CVCL:0321
35246016	1006	1008	HI	Disease	MESH:C538424
35246016	1009	1013	rats	Species	10116
35246016	1015	1031	ischemic lesions	Disease	MESH:D017202
35246016	1079	1091	inflammation	Disease	MESH:D007249
35246016	1129	1158	C-C chemokine receptor type 2	Gene	60463
35246016	1160	1164	CCR2	Gene	60463
35246016	1251	1255	CCR2	Gene	60463
35246016	1312	1325	neurotoxicity	Disease	MESH:D020258
35246016	1393	1405	inflammation	Disease	MESH:D007249
35246016	1428	1449	ischemic brain injury	Disease	MESH:D001930
35246016	1463	1467	CCR2	Gene	60463
35246016	Negative_Correlation	MESH:D010100	MESH:D009410
35246016	Association	MESH:D001930	60463
35246016	Association	MESH:D007249	60463
35246016	Association	MESH:D005947	MESH:D010100
35246016	Negative_Correlation	MESH:D005947	MESH:D009410

